EvoNK · EvoStem Ankylosing Spondylitis Immunity · Regeneration
Why is managing ankylosing spondylitis important?
Limitations of existing treatments and differences between LACELLIC
WHY LACELLIC HYBRID IS DIFFERENT?
Hybrid composition designed to both regulate immunity and protect joint tissue
The key to managing ankylosing spondylitis suggested by LACELLIC
LACELLIC Ankylosing Spondylitis Medical Tour
LACELLIC Medical Tour Package Ankylosing spondylitis is known to be an autoimmune disease that causes chronic inflammation centered on the sacroiliac joint that connects the spine and pelvis.
Unlike other autoimmune diseases, it is noted that it often begins at a relatively young age in the 20s and 30s.
In the beginning, it feels like stiffness in the lower back in the morning or pain when sitting for a long time.
In some cases, it can be easily overlooked as simple back pain, and as it progresses, persistent pain in the lower back and back, changes in posture, and decreased range of motion in joints may occur.
In particular, because the pain decreases with activity, there are many cases where it is accepted as a temporary improvement and passes.
However, the disease cannot be diagnosed based on these symptoms alone. Confirmation through imaging tests, blood tests (HLA-B27, etc.), and rheumatology consultation should be prioritized. Methods that have been considered together so far
For ankylosing spondylitis, drug treatments such as non-steroidal anti-inflammatory drugs and anti-rheumatic drugs and biological agents are widely used, and exercise therapy and posture management are also recommended.
These treatments play an important role in controlling pain and inflammation and maintaining function, and are planned and followed at the discretion of your medical team.
On the one hand, as it is a disease that starts at a young age and needs to be managed for a long time, research is continuing on approaches that look at both the malfunctioning immune response itself and the joint tissue burdened by repeated inflammation.
Immune cells and stem cells in our body - LACELLIC’s unique EvoNK·EvoStem hybrid
NK cells are immune cells that originally exist in our body and are known to play a role in recognizing abnormal cells and regulating immune responses.
Stem cells are cells with the ability to differentiate into various types of cells, and have been studied for a long time in relation to the environment in which damaged tissues are restored.
LACELLIC's EvoNK·EvoStem Hybrid is a program that combines these two. It consists of EvoNK, which regulates the immune response, and EvoStem, which monitors the regenerative environment of the entire body, including joints, through a combined intravenous (IV) method.
It is designed to minimize immune rejection by applying autologous platelet technology obtained from the patient's own blood. Here are the points we see together in the program:
• Control of chronic inflammatory signals directed to the spine • Aim to alleviate secondary damage to joint tissue • Control the source of autoreactive immune cells • Induce immune tolerance rather than indiscriminate suppression
This is a program designed from the perspective of re-establishing immune balance rather than unconditionally suppressing immunity.
However, for ankylosing spondylitis, the application and method vary depending on the extent of involvement, the progression of the stiffness, the drug treatment already received, and the current systemic condition.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
Also, please understand that this is not a concept of reversing stiffness that has already progressed, but rather an approach aimed at slowing down the progression and preserving remaining functions.
The priority is to continue the standard treatment, regular follow-up, and exercise therapy currently in progress at the discretion of the medical staff in charge, and the cell program is not a replacement for this.
Do not stop taking the medication arbitrarily and be sure to consult your doctor. Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home, and connection with global partner networks in Southeast Asia, the Middle East, and the Americas are also provided.
The basic plan is to organize everything from precise diagnosis to cell transplantation with a single visit to Korea.
This is followed by a review of repeat visit cycles and ongoing care based on the EvoX platform. The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
The scope of support for global partner network connections may vary depending on the partner organization and country, and may not be available in all regions. Treatment effectiveness may vary depending on the individual.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
